Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,717 shares at $2.11 ($6K) on 2022-06-29, disclosed to the SEC on 2022-07-01.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 127 | $260 | 4.7% |
| 2 | $2.08 | 127 | $264 | 4.8% |
| 3 | $2.09 | 127 | $265 | 4.8% |
| 4 | $2.07 | 136 | $282 | 5.1% |
| 5 | $2.08 | 100 | $208 | 3.7% |
| 6 | $2.12 | 136 |
| $288 |
| 5.2% |
| 7 | $2.09 | 136 | $284 | 5.1% |
| 8 | $2.04 | 136 | $277 | 5.0% |
| 9 | $2.01 | 136 | $273 | 4.9% |
| 10 | $2.02 | 136 | $275 | 5.0% |
| 11 | $1.98 | 136 | $269 | 4.9% |
| 12 | $1.95 | 136 | $265 | 4.8% |
| 13 | $1.94 | 136 | $264 | 4.8% |
| 14 | $1.97 | 143 | $282 | 5.1% |
| 15 | $1.99 | 139 | $277 | 5.0% |
| 16 | $2.01 | 143 | $287 | 5.2% |
| 17 | $2.11 | 143 | $302 | 5.4% |
| 18 | $2.06 | 26 | $54 | 1.0% |
| 19 | $2.06 | 132 | $272 | 4.9% |
| 20 | $2.11 | 143 | $302 | 5.4% |
| 21 | $2.08 | 143 | $297 | 5.4% |
| Total | $2.04 avg | 2,717 | $6K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |